ROIV

Roivant Sciences Stock Analysis

AI Rating

Low
  • Quality8/10
  • Growth 2/10
  • Value 0/10
Roivant Sciences sales and earnings growth
ROIV Growth
Fair
  • Revenue Y/Y -71.65%
  • EPS Y/Y -79.17%
  • FCF Y/Y 10.13%
Roivant Sciences gross and profit margin trends
ROIV Profitability
Low
  • Gross margin 84.40%
  • EPS margin -3629.20%
  • ROIC 5Y 157.31%
Roivant Sciences net debt vs free cash flow
ROIV Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Roivant Sciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks